Biotechnology

Monogram Biosciences, Inc. today announced that Wellpoint, Inc. has established a national Medical Policy Guideline for Monogram's Trofile Assay.

Joseph F. Finn, Jr., C.P.A. , Assignee of the assets of Spherics, Inc. for the benefit of creditors, announced today that all pharmaceutical intellectual property will be sold at a sealed bid auction on October 10, 2008.

Elanco, a division of Eli Lilly and Company , today announced that Lilly has signed an agreement to acquire the worldwide rights to the dairy cow supplement, Posilac , as well as the product's supporting operations, from Monsanto Company .

Today, the Parenteral Drug Association announced that Janet Woodcock, MD, Director, CDER, FDA will give the keynote presentation September 8th during the Opening Plenary Session of the 2008 PDA/FDA Joint Regulatory Conference .

GSI Group Inc. announced today the expiration of the initial offering period of the tender offer by its indirect wholly-owned subsidiary Eagle Acquisition Corporation for all outstanding shares of common stock of Excel Technology, Inc. . The initial offe

Lpath, Inc. , the category leader in therapeutic agents against bioactive lipids, reported the receipt of approximately $6.4 million in a private placement of unregistered shares of Class A common stock.

Rosetta Genomics, Ltd. announced today a collaboration with the National Institute of Health to identify microRNAs involved in the progression of the Human Immunodeficiency Virus , that may be used as potential drug targets.

MedPredict, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for multiple sclerosis therapies.